SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-021873
Filing Date
2019-03-29
Accepted
2019-03-29 19:46:54
Documents
2
Period of Report
2019-03-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1531
2 POA DOCUMENT poa.txt EX-24.3_844920 3417
  Complete submission text file 0001209191-19-021873.txt   6294
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Issuer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Jain Rita (Reporting) CIK: 0001707797 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35420 | Film No.: 19718394